Digg It
#1 in Business Subscribe Email Print

You are here: Home > Finance > Finance > Why Use Bridging Finance?

Tags

  • include
  • between
  • product
  • biological product
  • companies involved

  • Links

  • The Amazing Applications of Web Conference Calls
  • Horse Racing - Tips on Handicapping Maiden Sprints for Two Year Olds
  • How To Make The Most Out Of Interactive Web Conferencing
  • Digg It - Why Use Bridging Finance?

    Traditionally Bridging Finance, or Bridging Loan as it is also known, has been used to 'bridge' the financial gap between the sale of one
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    property and the purchase of another. Allowing borrowers to purchase the second property before selling their existing property.

    Numero
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    us other uses for Bridging Finance include -

    Allowing Buy to Let investors achieve a discount for a faster completion Auction purchases
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    where funds are required quickly to complete the purchase Entrepreneurs requiring a quick injection of cash to fund a new business oppo
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    rtunity Property developers, utilizing the speed of Bridging loan to quickly buy and sell on a property

    Fast Cash When You Need It Most
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro

    The traditional mortgage application route is well known for the snails pace at which it can sometimes operate. At the speed we live in
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    today's postmodern age this can be a very frustrating state of affairs.

    The property market has numerous opportunities but many can be l
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    ft on the shelf. Either through the chain collapsing or the lender not having funds in place quickly enough. To add to this a discount on
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    a property is a definite possibility if funding can be arranged quickly enough. Bridging Finance is a fast and easy solution to all thes
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    headaches.

    But why is this? It's very simple. Bridging Finance tends to be 'Non-Status'. Lenders consider the type and quality of the p
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    roperty as security as a measure of the lending possibility.

    Unlike traditional lending bridging underwriters are generally looking at m
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    inimum lending terms of between 3 months, 6 months or 12 months. But some lenders are even more flexible in this regard and will lend wit
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    no minimum period on the loan. Lending is available at up to 75% LTV (Loan-To-Value), in some cases 85% LTV may be available. Apart from
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    credit checks, the non-status factor is the same as mainstream non-status lending. The benefit is that the decision to lend is very much
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    faster.

    A Short Term Solution

    Bridging Finance can bridge a financial gap. But it should never really be considered a permanent solutio
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    n. A more permanent solution in the form of a regular mortgage should be considered if the property is to be held on to long-term. Or in
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    he case of a more speculative investment the borrower will sell the property to make a quick profit.

    Bridging Finance is flexible in ano
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ther way. In terms of the redemption date it can set as both 'open' with no definite end to the loan, or 'closed' with a set redemption d
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    te. It is advisable to only use the open variety when you are confident of the sale of a property or the replacing of the loan with a mor
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    e long-term finance solution.

    Bridging Finance remains the fastest and most appropriate loan type for making a property purchase quickly


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/89921/diggit-Why-Use-Bridging-Finance.html">Why Use Bridging Finance?</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/89921/diggit-Why-Use-Bridging-Finance.html]Why Use Bridging Finance?[/url]

    Related Articles:

    Everything Follows the Pitch

    Teamwork And The Importance Of Documenting

    The Good and The Bad of Working At Home

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com